<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1500666</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8<sup>+</sup> T lymphocytes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>G&#xf3;mez-Mor&#xf3;n</surname>
<given-names>&#xc1;lvaro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2300480"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsukalov</surname>
<given-names>Ilya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scagnetti</surname>
<given-names>Camila</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pertusa</surname>
<given-names>Clara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2301167"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lozano-Prieto</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mart&#xed;nez-Fleta</surname>
<given-names>Pedro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1571486"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Requena</surname>
<given-names>Silvia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mart&#xed;n</surname>
<given-names>Pilar</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/61865"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alfranca</surname>
<given-names>Aranzazu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1029725"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin-Gayo</surname>
<given-names>Enrique</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1208936"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Martin-Cofreces</surname>
<given-names>Noa B</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/32814"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Immunology Service, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Universitario La Princesa, IIS- Princesa, Universidad Aut&#xf3;noma de Madrid (UAM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid and 12 de Octubre Health Research Institute (imas12)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Medicine Faculty, Universidad Aut&#xf3;noma de Madrid (UAM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Videomicroscopy Unit, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Universidad Aut&#xf3;noma de Madrid (UAM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Area of Vascular Pathophysiology, Laboratory of Regulatory Molecules of Inflammatory Processes, Fundaci&#xf3;n Centro Nacional de Investigaciones Cardiovasculares-Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Enfermedades Infecciosas (CIBERINFECC), Instituto de Salud Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Fundaci&#xf3;n Centro Nacional de Investigaciones Cardiovasculares-Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Michael Loran Dustin, University of Oxford, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Noa B Martin-Cofreces, <email xlink:href="mailto:noa.martin@salud.madrid.org">noa.martin@salud.madrid.org</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1500666</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 G&#xf3;mez-Mor&#xf3;n, Tsukalov, Scagnetti, Pertusa, Lozano-Prieto, Mart&#xed;nez-Fleta, Requena, Mart&#xed;n, Alfranca, Martin-Gayo and Martin-Cofreces</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>G&#xf3;mez-Mor&#xf3;n, Tsukalov, Scagnetti, Pertusa, Lozano-Prieto, Mart&#xed;nez-Fleta, Requena, Mart&#xed;n, Alfranca, Martin-Gayo and Martin-Cofreces</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fimmu.2024.1411957" ext-link-type="doi">A Corrigendum on <article-title>Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8<sup>+</sup>&#xa0;T lymphocytes</article-title> By G&#xf3;mez-Mor&#xf3;n &#xc1;, Tsukalov I, Scagnetti C, Pertusa C, Lozano-Prieto M, Mart&#xed;nez-Fleta P, Requena S, Mart&#xed;n P, Alfranca A, Martin-Gayo E and Martin-Cofreces NB (2024) <italic>Front. Immunol</italic>.&#xa0;15:1411957. doi:&#xa0;<object-id>10.3389/fimmu.2024.1411957</object-id>
</related-article>
<kwd-group>
<kwd>protein translation</kwd>
<kwd>cell asymmetry</kwd>
<kwd>cytotoxic CD8<sup>+</sup>&#xa0;T lymphocytes</kwd>
<kwd>cytoskeleton</kwd>
<kwd>metabolism</kwd>
<kwd>mitochondria</kwd>
<kwd>T cell activation</kwd>
<kwd>immunological synapse</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="615"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>T Cell Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an error. The name &#x201c;70S&#x201d; was used to name mitochondrial ribosomes instead of &#x201c;55S&#x201d;.</p>
<p>A correction has been made to <bold>Abstract</bold>, <italic>Introduction</italic>. This sentence previously stated:</p>
<p>&#x201c;Mitochondria play a role in regulating CTL function by controlling processes such as calcium flux, providing the necessary energy through oxidative phosphorylation, and its own protein translation on 70S ribosomes.&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;Mitochondria play a role in regulating CTL function by controlling processes such as calcium flux, providing the necessary energy through oxidative phosphorylation, and its own protein translation on 55S ribosomes.&#x201d;</p>
<p>A correction has also been made to <bold>Abstract</bold>, <italic>Methods</italic>. This sentence previously stated:</p>
<p>&#x201c;Here, we investigated the importance of cytosolic protein synthesis in human CTLs after early TCR activation and CD28 co-stimulation for the dynamic reorganisation of the cytoskeleton, mitochondria, and lytic granules through short-term chemical inhibition of 80S ribosomes by cycloheximide and 80S and 70S by puromycin.&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;Here, we investigated the importance of cytosolic protein synthesis in human CTLs after early TCR activation and CD28 co-stimulation for the dynamic reorganisation of the cytoskeleton, mitochondria, and lytic granules through short-term chemical inhibition of 80S ribosomes by cycloheximide and 80S and 55S by puromycin.&#x201d;</p>
<p>A correction has been made to <bold>Introduction</bold>, Paragraph 3. This sentence previously stated:</p>
<p>&#x201c;CTLs require correct translation at mitochondrial 70S ribosomes to help CD8+ cytotoxic T cell-mediated prolonged killing (39).&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;CTLs require correct translation at mitochondrial 55S ribosomes to help CD8+ cytotoxic T cell-mediated prolonged killing (39).&#x201d;</p>
<p>A correction has been made to <bold>Results</bold>, Eukaryotic protein translation inhibition affects tubulin cytoskeleton dynamics and TCR signalling of human cytotoxic T lymphocytes, Paragraph 1. This sentence previously stated:</p>
<p>&#x201c;Indeed, PURO has also been used to inhibit mitochondrial 70S ribosomes <italic>in vitro</italic> (47).&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;Indeed, PURO has also been used to inhibit mitochondrial 55S ribosomes <italic>in vitro</italic> (47).&#x201d;</p>
<p>A correction has also been made to <bold>Results</bold>, Eukaryotic protein translation inhibition affects tubulin cytoskeleton dynamics and TCR signalling of human cytotoxic T lymphocytes, Paragraph 3. This sentence previously stated:</p>
<p>&#x201c;Indeed, inhibition of 70S mitochondrial ribosomes could also increase the effect in CTLs after puromycin treatment.&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;Indeed, inhibition of 55S mitochondrial ribosomes could also increase the effect in CTLs after puromycin treatment.&#x201d;</p>
<p>A correction has been made to <bold>Discussion</bold>, Paragraph 1. This sentence previously stated:</p>
<p>&#x201c;A site is used by puromycin to enter the ribosome and bind, causing rapid chain termination by covalently attaching to the C-terminus of the nascent chain, producing a Cterminal puromycylated polypeptide (46); puromycin is also known to act in the 80S and 70S ribosomes (47).&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;A site is used by puromycin to enter the ribosome and bind, causing rapid chain termination by covalently attaching to the C-terminus of the nascent chain, producing a Cterminal puromycylated polypeptide (46); puromycin is also known to act in the 80S and 55S ribosomes (47).&#x201d;</p>
<p>A correction has also been made to <bold>Discussion</bold>, Paragraph 6. This sentence previously stated:</p>
<p>&#x201c;Here, we demonstrate the relevant role of cytosolic protein translation in facilitating human CTL functionality that is probably potentiated by mitochondrial ribosomes, as deduced by the potential effect of puromycin on 70S ribosomes.&#x201d;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201c;Here, we demonstrate the relevant role of cytosolic protein translation in facilitating human CTL functionality that is probably potentiated by mitochondrial ribosomes, as deduced by the potential effect of puromycin on 55S ribosomes.&#x201d;</p>
<p>The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>